|
Volumn 139, Issue 2, 2003, Pages 213-214
|
Complications in dermatologic surgery: How safe is safe?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIBIOTIC AGENT;
THROMBOCYTE SLOWING FACTOR;
WARFARIN;
ALLERGIC REACTION;
AMBULATORY SURGERY;
ANTIBIOTIC PROPHYLAXIS;
BURN;
CANCER SURGERY;
CHEMOSURGERY;
CLINICAL TRIAL;
EDITORIAL;
GENERAL ANESTHESIA;
GENERAL SURGERY;
GRAFT REJECTION;
HEAD AND NECK SURGERY;
HEALTH CARE QUALITY;
HEMATOMA;
HOSPITAL;
HUMAN;
INCIDENCE;
INFECTION RATE;
INFECTION RISK;
LAPAROSCOPIC SURGERY;
LIPOSUCTION;
LOCAL ANESTHESIA;
MALPRACTICE;
MEDICAL SOCIETY;
MEDICAL SPECIALIST;
MORTALITY;
NERVE PARALYSIS;
OPERATING ROOM;
ORTHOPEDIC SURGERY;
PLASTIC SURGERY;
POSTOPERATIVE CARE;
POSTOPERATIVE COMPLICATION;
POSTOPERATIVE HEMORRHAGE;
POSTOPERATIVE INFECTION;
POSTOPERATIVE PERIOD;
PREOPERATIVE TREATMENT;
PRIORITY JOURNAL;
QUALITY CONTROL;
SAFETY;
SEDATION;
SKIN CANCER;
SKIN SURGERY;
STATISTICAL SIGNIFICANCE;
SURGICAL RISK;
AMBULATORY SURGICAL PROCEDURES;
DERMATOLOGY;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
INCIDENCE;
MALE;
MOHS SURGERY;
POSTOPERATIVE COMPLICATIONS;
RISK ASSESSMENT;
RISK FACTORS;
SENSITIVITY AND SPECIFICITY;
SKIN DISEASES;
UNITED STATES;
|
EID: 0037319927
PISSN: 0003987X
EISSN: None
Source Type: Journal
DOI: 10.1001/archderm.139.2.213 Document Type: Editorial |
Times cited : (21)
|
References (12)
|